File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Coagulation, blood loss and platelet activation during isoflurane or sevoflurane anesthesia

TitleCoagulation, blood loss and platelet activation during isoflurane or sevoflurane anesthesia
Authors
Issue Date2008
PublisherAmerican Society of Anesthesiologists. The Journal's web site is located at http://www.asa-abstracts.com
Citation
The 2008 Annual Meeting of the American Society of Anesthesiologists (ASA), Orlando, FL., 18-22 October 2008. In ASA Annual Meeting Abstracts, 2008, abstract no. A1619 How to Cite?
AbstractINTRODUCTION: Sevoflurane has been shown to inhibit platelet aggregation1,2. This study investigates whether sevoflurane causes different coagulation changes, blood loss and platelet activation compared to isoflurane. METHODS: With IRB approval, patients undergoing elective joint arthroplasty were recruited. Patients discontinued their NSAID and no LMWH were used. They were allocated randomly to receive either sevoflurane (Group S) or isoflurane (Group I) anesthesia. Opioids and femoral blocks were employed at the discretion of the anesthesiologists. Intravenous fluids were prescribed using a strict protocol and red cell transfused if hemoglobin dropped below 8g/dL. All operations were performed by the surgeon authors (WMT & KYC) using a standardized technique. Blood is collected for complete blood count, prothrombin time, activated partial thromboplastin time, thrombelastography (TEG®) and plasma soluble CD40 ligand (sCD40L) concentration before induction and in PACU. Intraoperative and postoperative blood loss was recorded. Native TEG® measurement was performed using the TEG® 5000 (Haemoscope Corp, IL, USA). sCD40L was measured using platelet poor plasma (PPP) with a commercial ELISA kit (R&D Systems, MN, USA). PPP was prepared by centrifugation of EDTA blood at 10,000g, 4 oC for 10 minutes. RESULTS: 20 patients were recruited in each group (M/F = 4/16 and 6/14; age = 65±15 and 64±12, Group S and I). There was no difference in all TEG® or other coagulation parameters between the groups (table1), nor in blood loss, fluid requirement or change in Hb (table2).[table1][table2]No patient required transfusion. However patients in Group S had significantly lower plasma sCD40L concentrations at end of surgery.[figure1]Conclusion Sevoflurane reduces platelet activation without impairing coagulation or increasing blood loss compared to isoflurane. REFERENCES: 1. Anesthesiology 1996;85:1447. 2. Can J Anaesth 1997;44:1157.
Persistent Identifierhttp://hdl.handle.net/10722/112780
ISSN

 

DC FieldValueLanguage
dc.contributor.authorNg, JKFen_HK
dc.contributor.authorTsang, SFen_HK
dc.contributor.authorLeung, SWSen_HK
dc.contributor.authorTang, WMen_HK
dc.contributor.authorChiu, PKYen_HK
dc.date.accessioned2010-09-26T03:46:53Z-
dc.date.available2010-09-26T03:46:53Z-
dc.date.issued2008en_HK
dc.identifier.citationThe 2008 Annual Meeting of the American Society of Anesthesiologists (ASA), Orlando, FL., 18-22 October 2008. In ASA Annual Meeting Abstracts, 2008, abstract no. A1619-
dc.identifier.issn1548-2553-
dc.identifier.urihttp://hdl.handle.net/10722/112780-
dc.description.abstractINTRODUCTION: Sevoflurane has been shown to inhibit platelet aggregation1,2. This study investigates whether sevoflurane causes different coagulation changes, blood loss and platelet activation compared to isoflurane. METHODS: With IRB approval, patients undergoing elective joint arthroplasty were recruited. Patients discontinued their NSAID and no LMWH were used. They were allocated randomly to receive either sevoflurane (Group S) or isoflurane (Group I) anesthesia. Opioids and femoral blocks were employed at the discretion of the anesthesiologists. Intravenous fluids were prescribed using a strict protocol and red cell transfused if hemoglobin dropped below 8g/dL. All operations were performed by the surgeon authors (WMT & KYC) using a standardized technique. Blood is collected for complete blood count, prothrombin time, activated partial thromboplastin time, thrombelastography (TEG®) and plasma soluble CD40 ligand (sCD40L) concentration before induction and in PACU. Intraoperative and postoperative blood loss was recorded. Native TEG® measurement was performed using the TEG® 5000 (Haemoscope Corp, IL, USA). sCD40L was measured using platelet poor plasma (PPP) with a commercial ELISA kit (R&D Systems, MN, USA). PPP was prepared by centrifugation of EDTA blood at 10,000g, 4 oC for 10 minutes. RESULTS: 20 patients were recruited in each group (M/F = 4/16 and 6/14; age = 65±15 and 64±12, Group S and I). There was no difference in all TEG® or other coagulation parameters between the groups (table1), nor in blood loss, fluid requirement or change in Hb (table2).[table1][table2]No patient required transfusion. However patients in Group S had significantly lower plasma sCD40L concentrations at end of surgery.[figure1]Conclusion Sevoflurane reduces platelet activation without impairing coagulation or increasing blood loss compared to isoflurane. REFERENCES: 1. Anesthesiology 1996;85:1447. 2. Can J Anaesth 1997;44:1157.-
dc.languageengen_HK
dc.publisherAmerican Society of Anesthesiologists. The Journal's web site is located at http://www.asa-abstracts.com-
dc.relation.ispartofASA Annual Meeting Abstractsen_HK
dc.titleCoagulation, blood loss and platelet activation during isoflurane or sevoflurane anesthesiaen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailNg, JKF: jkfng@hkucc.hku.hken_HK
dc.identifier.emailLeung, SWS: swsleung@hkucc.hku.hken_HK
dc.identifier.emailTang, WM: wmtanga@hkucc.hku.hken_HK
dc.identifier.emailChiu, PKY: pkychiu@hkucc.hku.hken_HK
dc.identifier.authorityNg, JKF=rp00544en_HK
dc.identifier.authorityLeung, SWS=rp00235en_HK
dc.identifier.authorityChiu, PKY=rp00379en_HK
dc.identifier.hkuros168532en_HK
dc.identifier.hkuros168520-
dc.publisher.placeUnited States-
dc.publisher.placeUnited States-
dc.description.otherAmerican Society of Anesthesiologists Annual Meeting, Orlando, Florida, USA, 18-22 Oct 2008, Abstract no. A1619-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats